{"product_id":"giefoni-gefitinib-250mg","title":"Giefoni (Gefitinib)","description":"\u003cstrong\u003e[Indications]\u003c\/strong\u003e\r\n\r\nGiefoni is a tyrosine kinase inhibitor (TKI) used in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) where epidermal growth factor receptor (EGFR) exon 19 is absent or exon 21 (L858R) replaces the mutant type.\r\n\r\nMedication limitations: the safety and efficacy of Giefoni for EGFR mutations other than exon 19 deletion or exon 21 (L858R) replacement mutations have not been determined\r\n\r\n\u003cstrong\u003e[\u003c\/strong\u003e\u003cstrong\u003eHow to take the drug]\u003c\/strong\u003e\r\n\r\n1. Therapy period\r\n\r\nRecommended dosage: 250mg, taken orally, once daily; Not with food or with food.\r\n\r\n2. Dosage form specification:\r\n\u003cul\u003e\r\n \t\u003cli\u003eTablet, 250mg.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n3. Contraindications\r\n\r\nNone\r\n\r\n\u003cstrong\u003e[Warnings and precautions]\u003c\/strong\u003e\r\n\r\n● \u003cstrong\u003eInterstitial lung disease (ILD) :\u003c\/strong\u003e there may be ILD during giffornia.  If the ILD is confirmed, the medication is terminated.\r\n\r\n● \u003cstrong\u003eH\u003c\/strong\u003e\u003cstrong\u003eepatotoxicity: \u003c\/strong\u003eregular liver function testing. The presence of elevated ALT and\/or AST at level 2 or higher requires a drug break. Discontinue medication if severe liver damage occurs\r\n\r\n●\u003cstrong\u003eGastrointestinal perforation\u003c\/strong\u003e: discontinue medication if gastrointestinal perforation occurs.\r\n\r\n●\u003cstrong\u003eDiarrhea\u003c\/strong\u003e: medication suspension is required for diarrhea of grade 3 or higher.\r\n\r\n●\u003cstrong\u003eEye diseases include keratitis\u003c\/strong\u003e: severe or worsening eye diseases include signs and symptoms of keratitis requiring medication discontinuation, and discontinuation of medication for prolonged ulcerative keratitis.\r\n\r\n●\u003cstrong\u003eCowhide and exfoliating skin diseases\u003c\/strong\u003e: drug suspension is required for skin reactions or peeling at grade 3 or higher.\r\n\r\n●\u003cstrong\u003eE\u003c\/strong\u003e\u003cstrong\u003embryonic toxicity\u003c\/strong\u003e: may cause fetal damage. Effective contraceptive measures are recommended to avoid potential fetal risks.\r\n\r\n\u003cstrong\u003e[Side-effect]\u003c\/strong\u003e\r\n\r\nMore than 20 percent of the most common side effects in the placebo group were skin reactions and diarrhea.\r\n\r\n\u003cstrong\u003e[How to store the drug]\u003c\/strong\u003e\r\n\r\nKeep this medicine at dark, cool and dry place.","brand":"Tongmeng (Lao) Pharmaceutical \u0026 Food Co., Ltd.（TLPH）","offers":[{"title":"Default Title","offer_id":44797946789931,"sku":"RL1420230901102","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/1655977414-14b07825315253a.png?v=1787022082","url":"https:\/\/xomeds.com\/products\/giefoni-gefitinib-250mg","provider":"XOMEDS","version":"1.0","type":"link"}